N/A N=27 Basic Science

The Effect of Clopidogrel on Coated-Platelets in Patients Undergoing Cardiac Catheterization

Coronary Artery Disease · Chest Pain

Bottom Line

View on ClinicalTrials.gov: NCT00644657 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Oct 2011

Primary outcome: Primary: The Percentage of Coated Platelets After the Administration of Clopidogrel in Patients Undergoing Cardiac Catheterization and/or Angioplasty — 32.8 Percent of platelets that are coated.

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Clopidogrel (Drug)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: University of Oklahoma
Primary completion: Sep 2008

Outcome Measures

Outcome	Result	p-value
PRIMARY The Percentage of Coated Platelets After the Administration of Clopidogrel in Patients Undergoing Cardiac Catheterization and/or Angioplasty	32.8	—
SECONDARY The Percentage of Coated Platelets After Coronary Angiography and/or PCI	33.9	—

Summary

This study will explore the effect of clopidogrel on coated-platelets in patients who are given a loading dose before diagnostic catheterization or percutaneous coronary intervention. We hypothesis that clopidogrel will reduce the percentage of platelets that are coated and therefore more hypercoagulable.

Eligibility Criteria

Inclusion Criteria

Patients given clopidogrel loading dose before scheduled catheterization or percutaneous intervention

Exclusion Criteria

Acute coronary syndrome
Unable to tolerate clopidogrel

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00644657). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.